NeuroMetrix, Inc. (NURO) Financials
NURO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 21.3 million | 1.4 million |
2023-06-30 | 22.8 million | 1.4 million |
2023-03-31 | 23.6 million | 1.6 million |
2022-12-31 | 24.7 million | 1.3 million |
NURO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.2 million | 221268 |
2023-06-30 | -1.5 million | 132745 |
2023-03-31 | -1.1 million | 165361 |
2022-12-31 | -1.5 million | 168139 |
NURO Net Income
No data available :(
NURO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 17.6 million | - | 122870 |
2023-06-30 | 19.6 million | - | 152143 |
2023-03-31 | 20.3 million | - | 180345 |
2022-12-31 | 21.2 million | - | 207516 |
NURO Shares Outstanding
NURO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 138176 | 592654 | 1.2 million | 943795 |
2023-06-30 | - | 753509 | 1.2 million | 744963 |
2023-03-31 | - | 699425 | 1.4 million | 815872 |
2022-12-31 | 13432 | 538395 | 918214 | 629969 |
NURO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 1.2 million | 421382 |
2023-06-30 | 1.7 million | 536486 |
2023-03-31 | 1.7 million | 526372 |
2022-12-31 | 1.8 million | 617267 |
NURO
Price: $4.60
52 week price:
Earnings Per Share: -6.27 USD
P/E Ratio: -0.59
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 39500
Ebitda: -2.8 millionMarket Capitalization: 7.8 million